|
ACTR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.089600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.118200E-02 |
| Normal-vs-Stage2 |
2.344100E-02 |
| Normal-vs-Stage3 |
4.932100E-02 |
| Normal-vs-Stage4 |
7.983600E-03 |
| Stage1-vs-Stage2 |
2.029600E-01 |
| Stage1-vs-Stage3 |
4.716600E-01 |
| Stage1-vs-Stage4 |
9.648200E-02 |
| Stage2-vs-Stage3 |
5.863800E-01 |
| Stage2-vs-Stage4 |
7.980600E-01 |
| Stage3-vs-Stage4 |
3.992000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.809600E-02 |
| Normal-vs-AfricanAmerican |
4.044000E-01 |
| Normal-vs-Asian |
1.132080E-02 |
| Caucasian-vs-AfricanAmerican |
5.751400E-01 |
| Caucasian-vs-Asian |
2.723400E-01 |
| AfricanAmerican-vs-Asian |
1.583370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.917930E-02 |
| Normal-vs-Female |
3.334000E-02 |
| Male-vs-Female |
4.280200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.403580E-01 |
| Normal-vs-Age(41-60Yrs) |
2.141400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.959800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.945600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.608400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.313800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.890000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.232000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.475010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.427200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.706600E-01 |
| Classical-VS-Follicular |
2.399800E-03 |
| Classical-VS-Other |
1.610780E-01 |
| Classical-VS-Normal |
1.076040E-01 |
| Tall-VS-Follicular |
6.769500E-02 |
| Tall-VS-Other |
2.690200E-01 |
| Tall-VS-Normal |
5.350600E-01 |
| Follicular-VS-Other |
7.443600E-01 |
| Follicular-VS-Normal |
1.575620E-03 |
| Other-VS-Normal |
7.620300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.977300E-03 |
| Normal-vs-N1 |
3.822400E-03 |
| N0-vs-N1 |
4.979800E-01 |
|
|
